News Mylan to develop Botox biosimilar with Revance Mylan takes aim at Allergan's off-patent blockbuster
News Samsung Bioepis Herceptin biosimilar approved in EU Mylan and Biocon resolve biosimilar manufacturing issues
News FDA rejects Mylan and Biocon biosimilar, citing manufacturin... Neulasta biosimilar hits trouble with regulators because of manufacturing issues
News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
News Tonix ends 16-year hiatus in fibromyalgia treatment Tonix Pharma is preparing to launch a new therapy for fibromyalgia that analysts predict could make hundreds of millions of dollars in annual sales.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
